You are here

Clinical Trials

Company, FDA held a meeting to discuss trials in bunion, "tummy tuck" patients
Rozanolixizumab touted as possible alternative to standard therapy of corticosteroids, intravenous immunoglobulin
Myovant’s drug would offer a new oral, once-daily treatment option
Mesh Implants, Now Banned by FDA, Work as Well as Hysterectomy
Reductions in CV Mortality, Bleeding Risk Observed in Some Patients
But Are “Polypills”a Good Idea?
‘The Perfect Drug for Trauma-Focused Psychotherapy’
Researcher Made Himself Guinea Pig to Test the Drug
Treatment Shorter, Less Complicated Than Typical Regimen
Zip Device Faster to Apply, Minimizes Scarring
Overall Survival 4.3 Months’ vs. 1.5 Months for Traditional Regimens
Will Have a Longer Shelf Life Than Current, Expired Stockpile
Study Data Indicate Drug May Provide Complete Remission in PV
Nivolumab/Chemotherapy Arm Shows No Unexpected Toxicities
ASCO Results Exceed Researchers’ Expectations
22% of Patients Progression-Free Two Years Later
Currently Incurable RRP Affects 20,000 Cases in the U.S.
Novel Therapy Can Greatly Increase Stem, Immune Cell Numbers in Seven Days
Bone Marrow Cleared of Leukemia in Almost 60% of Patients
Addressing an Unmet Need in Patients With Burdensome Disease
OCA Meets Primary Endpoint of Improvement in Liver Fibrosis
Treatment Improves Motor Function, Preserves Neurons
Possible One-Time Treatment for Rare Pediatric CLN2 Disease
Key Finding Shows 65% of Patients Diagnosed With Early-Stage Lung Cancer
Drug Could Treat Cognitive Dysfunction and Other Symptoms
“EsophaCap” Uses Genetic Biomarkers to Detect Dangerous Changes in the Cells Lining the Esophagus
Approximately 40% of Patients With BRAF-Mutated Biliary Tract Cancer Respond Well
iPSC Therapy Designed to Salvage Eye, Prevent Vision Loss